Short communication5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
Section snippets
Acknowledgements
The present study was supported in part by the William K. Warren Foundation.
References (41)
- et al.
5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex
Neuropsychopharmacology
(1999) - et al.
SR46349-B, a 5-HT2A/2C receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
Neuropsychopharmacology
(2002) - et al.
Serotonin (5-HT)2A receptor activation enhances dialysis levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats
Neuropharmacology
(1999) - et al.
Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists
Eur. J. Pharmacol.
(1994) - et al.
DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum
Brain Res.
(1995) - et al.
DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release
Brain Res.
(2001) - et al.
R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens
Eur. J. Pharmacol.
(1995) - et al.
R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex
Brain Res.
(1996) - et al.
R(+)-8-OH-DPAT, a selective 5-HT1A receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex
Brain Res.
(2000) - et al.
Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex
Prog. Neuro-Psychopharmacol. Biol. Psychiat.
(1999)
5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner
Brain Res.
(2002)
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
Neuropharmacology
(1998)
Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(1997)
M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex
Brain Res.
(2001)
5-HT2A and 5-HT2C/2B receptor subtypes respectively modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
Neuropsychopharmacology
(2002)
5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL100,907 and the amphetamine analogue, 3,4-methlenedioxymethamphetamine
Eur. J. Pharmacol.
(1992)
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—a PET study with [11C]raclopride
Neuropsychopharmacology
(1999)
Serotonin 5-HT2 receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat
J. Neurochem.
(2000)
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method
Proc. Nat. Acad. Sci. USA
(1997)
Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens
J. Neurosci.
(1999)
Cited by (0)
Copyright © 2003 Elsevier Science B.V. All rights reserved.